Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 20 - Number 5


Review Article

CDK9: Therapeutic Perspective in HCC Therapy

, 20(5): 318 - 324

Jędrzej Borowczak*, Krzysztof Szczerbowski, Ewa Stec, Dariusz Grzanka and Łukasz Szylberg


DOI: 10.2174/1568009620666200212124357



Review Article

A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer

, 20(5): 325 - 334

Li Liu and Xiaomao Li*


DOI: 10.2174/1568009620666200228123754



Review Article   Open Access

Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development

, 20(5): 335 - 340

Mubeena P.M. Mariyath, Mehdi H. Shahi*, Shirin Farheen, Mohd Tayyab, Nabeela Khanam and Asif Ali


DOI: 10.2174/1568009618666180102111539



Review Article (Mini-Review)

Idronoxil as an Anticancer Agent: Activity and Mechanisms

, 20(5): 341 - 354

Kate Porter*, Walter Douglas Fairlie, Olivier Laczka, Frederic Delebecque and John Wilkinson


DOI: 10.2174/1568009620666200102122830



Research Article

Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer

, 20(5): 355 - 363

Dong Ma , Shao-Bei Fan , Na Hua, Guo-Hua Li, Quan Chang and Xiao Liu *


DOI: 10.2174/1568009620666200102123635



Research Article

The Potential Targets and Mechanisms of a Carbazole and Pyrazole Containing Anticancer Compound

, 20(5): 364 - 371

Jingping Xie * and John C. Gore


DOI: 10.2174/1568009620666200115162343



Research Article

Fas Ligand Enhances Apoptosis of Human Lung Cancer Cells Cotreated with RIG-I-like Receptor Agonist and Radiation

, 20(5): 372 - 381

Yoshiaki Sato, Hironori Yoshino*, Eichi Tsuruga and Ikuo Kashiwakura


DOI: 10.2174/1568009620666200115161717





Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog